Analytical procedures are developed and validated according to good laboratory practices developed primarily from Shah et al and OECD guidelines. All phases of the analytical process are monitored daily by internal auditors who are appointed for each project. External audits can be arranged if required by the sponsor.

Our analytical reports have been submitted and accepted by regulatory authorities in Australia, Canada, France, Germany, Holland, Ireland, Italy, Spain, South Africa, Turkey, and the UK.

Over the years a large number of validated analytical methods have been developed to measure the concentrations of drugs and their metabolites in biological fluids including serum, plasma, whole blood, and synovial fluid. Collectively our staff has been involved in over 500 research studies, which were analysed by HPLC, GC, GC/MS, or LCMSMS.

Traditionally our clients have consisted of CRO's who may or may not have their own analytical facilities, and also multi-national pharmaceutical companies who have found it cost effective to make use of our expertise, independance, and experience.